Larson Financial Group LLC Bristol Myers Squibb CO Transaction History

Larson Financial Group LLC

$1.45 Billion
Q2 2024

A detailed history of Larson Financial Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Larson Financial Group LLC holds 8,771 shares of BMY stock, worth $466,529. This represents 0.03% of its overall portfolio holdings.

Number of Shares

8,771

Previous 3,907 124.49%

Holding current value

$466,529

Previous $211,000 72.51%

% of portfolio

0.03%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$40.25 - $52.99 $195,776 - $257,743	4,864 Added 124.49%	8,771 $364,000
Q1 2024 May 03, 2024	SELL	$47.98 - $54.4 $9,691 - $10,988	-202 Reduced 4.92%	3,907 $211,000
Q4 2023 Feb 01, 2024	SELL	$48.48 - $57.85 $9,259 - $11,049	-191 Reduced 4.44%	4,109 $210,000
Q3 2023 Nov 03, 2023	BUY	$57.89 - $64.73 $19,277 - $21,555	333 Added 8.39%	4,300 $249,000
Q2 2023 Aug 03, 2023	SELL	$63.71 - $70.74 $1.59 Million - $1.76 Million	-24,927 Reduced 86.27%	3,967 $253,000
Q1 2023 May 04, 2023	BUY	$65.71 - $74.53 $20,041 - $22,731	305 Added 1.07%	28,894 $2 Million
Q4 2022 Feb 03, 2023	BUY	$68.48 - $81.09 $237,831 - $281,625	3,473 Added 13.83%	28,589 $2.06 Million
Q3 2022 Nov 03, 2022	BUY	$0.13 - $76.84 $2,801 - $1.66 Million	21,552 Added 604.71%	25,116 $1.79 Million
Q2 2022 Aug 04, 2022	BUY	$72.62 - $79.98 $28,539 - $31,432	393 Added 12.39%	3,564 $274,000
Q1 2022 May 05, 2022	SELL	$61.48 - $73.72 $80,784 - $96,868	-1,314 Reduced 29.3%	3,171 $232,000
Q4 2021 Feb 03, 2022	BUY	$53.63 - $62.52 $71,542 - $83,401	1,334 Added 42.34%	4,485 $280,000
Q3 2021 Nov 04, 2021	SELL	$59.17 - $69.31 $17,218 - $20,169	-291 Reduced 8.45%	3,151 $186,000
Q2 2021 Aug 10, 2021	BUY	$61.91 - $67.42 $19,130 - $20,832	309 Added 9.86%	3,442 $230,000
Q1 2021 May 06, 2021	SELL	$59.34 - $66.74 $9,316 - $10,478	-157 Reduced 4.77%	3,133 $198,000
Q4 2020 Jan 14, 2021	SELL	$57.74 - $65.43 $36,029 - $40,828	-624 Reduced 15.94%	3,290 $204,000
Q3 2020 Oct 08, 2020	BUY	$57.43 - $63.64 $574 - $636	10 Added 0.26%	3,914 $236,000
Q2 2020 Jul 10, 2020	BUY	$54.82 - $64.09 $13,979 - $16,342	255 Added 6.99%	3,904 $230,000
Q1 2020 Apr 09, 2020	BUY	$46.4 - $67.43 $17,910 - $26,027	386 Added 11.83%	3,649 $203,000
Q4 2019 Jan 10, 2020	BUY	$49.21 - $64.19 $12,893 - $16,817	262 Added 8.73%	3,263 $209,000
Q3 2019 Oct 11, 2019	BUY	$42.77 - $50.71 $54,275 - $64,350	1,269 Added 73.27%	3,001 $152,000
Q2 2019 Jul 16, 2019	BUY	$44.62 - $49.34 $22,310 - $24,670	500 Added 40.58%	1,732 $79,000
Q4 2018 Feb 07, 2019	BUY	$48.76 - $63.23 $60,072 - $77,899	1,232 New	1,232 $64,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.

Account

Larson Financial Group LLC Bristol Myers Squibb CO Transaction History